BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7031419)

  • 21. Potentiation of glucose-stimulated insulin release by tolazamide and paradoxical absence of glucose facilitation (Staub effect) in non-insulin-dependent diabetes.
    Reich A; Abraira C; Brunken R; Soneru I
    Metabolism; 1986 Apr; 35(4):367-70. PubMed ID: 3515119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in plasma glucose, insulin (IRI), glucagon (IRG) and free fatty acids (FFA) following alanine loading in hyperthyroid patients.
    Ida H; Yamamoto T; Ninomiya H; Sasaki H; Asano T; Okumura M
    Endocrinol Jpn; 1987 Dec; 34(6):937-45. PubMed ID: 3330025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentrations.
    Golay A; Swislocki AL; Chen YD; Jaspan JB; Reaven GM
    J Clin Endocrinol Metab; 1986 Aug; 63(2):481-4. PubMed ID: 3522620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucagon-insulin balance in genetically lean or fat chickens.
    Leclercq B; Simon J; Karmann H
    Diabete Metab; 1988; 14(5):641-5. PubMed ID: 3069508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Staub-Traugott effect. Evidence for multifactorial regulation of a physiological function.
    Wajngot A; Grill V; Efendić S; Cerasi E
    Scand J Clin Lab Invest; 1982 Jun; 42(4):307-13. PubMed ID: 6753099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement of glucose-primed intravenous glucose tolerance and correction of acute insulin decrement by glipizide in type II diabetes.
    Ravanam A; Jeffery J; Nehlawi M; Abraira C
    Metabolism; 1991 Nov; 40(11):1173-7. PubMed ID: 1943745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved tolerance to successive glucose loads in acromegaly.
    Abraira C; Lawrence AM
    Metabolism; 1977 Mar; 26(3):287-93. PubMed ID: 319324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fasting and postprandial plasma glucagon and glucagon-like immunoreactivity are normal in obese Pima Indians.
    Vasquez B; Nagulesparan M; Unger RH
    Horm Metab Res; 1983 May; 15(5):218-20. PubMed ID: 6347855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin sensitivity of blood glucose versus insulin sensitivity of blood free fatty acids in normal, obese, and obese-diabetic subjects.
    Belfiore F; Iannello S; Camuto M; Fagone S; Cavaleri A
    Metabolism; 2001 May; 50(5):573-82. PubMed ID: 11319720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma catecholamines and carbohydrate metabolism in patients with acute myocardial infarction.
    Christensen NJ; Videbaek J
    J Clin Invest; 1974 Aug; 54(2):278-86. PubMed ID: 4847245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of starvation diabetes: a study with double tracer and indirect calorimetry.
    Fery F; d'Attellis NP; Balasse EO
    Am J Physiol; 1990 Dec; 259(6 Pt 1):E770-7. PubMed ID: 2260646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood sugar, serum insulin and serum non-esterified fatty acid levels during thiopentone anaesthesia in dogs.
    Toso CF; Rodríguez RR; Renauld A; Sverdlik RC; Linares LM
    Can J Anaesth; 1993 Jan; 40(1):38-45. PubMed ID: 8425241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbohydrate metabolism in pregnancy. VI. Plasma fuels, insulin, liver composition, gluconeogenesis, and nitrogen metabolism during late gestation in the fed and fasted rat.
    Herrera E; Knopp RH; Freinkel N
    J Clin Invest; 1969 Dec; 48(12):2260-72. PubMed ID: 5355339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response of insulin, glucagon, lactate, and nonesterified fatty acids to glucose in visceral obesity with and without NIDDM: relationship to hypertension.
    Iannello S; Campione R; Belfiore F
    Mol Genet Metab; 1998 Mar; 63(3):214-23. PubMed ID: 9608544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
    DeFronzo RA; Barzilai N; Simonson DC
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ethanol-induced changes in plasma glucose, insulin and glucagon in fed and fasted rats.
    Potter DE; Morris JW
    Experientia; 1980 Aug; 36(8):1003-4. PubMed ID: 7002581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The disposal of an intravenously administered amino acid load across the human forearm.
    Abumrad NN; Rabin D; Wise KL; Lacy WW
    Metabolism; 1982 May; 31(5):463-70. PubMed ID: 7043179
    [No Abstract]   [Full Text] [Related]  

  • 38. Short-term fasting is a mechanism for the development of euglycemic ketoacidosis during periods of insulin deficiency.
    Burge MR; Hardy KJ; Schade DS
    J Clin Endocrinol Metab; 1993 May; 76(5):1192-8. PubMed ID: 8496310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of oral L-carnitine supplementation on insulin sensitivity indices in response to glucose feeding in lean and overweight/obese males.
    Galloway SD; Craig TP; Cleland SJ
    Amino Acids; 2011 Jul; 41(2):507-15. PubMed ID: 20963457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma glucagon response to intravenous alanine in obese and non-obese subjects.
    Asano T; Ninomiya H; Kan K; Yamamoto T; Okumura M
    Endocrinol Jpn; 1989 Oct; 36(5):767-73. PubMed ID: 2695321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.